Jump to ContentJump to Main Navigation
Quantitative Evaluation of HIV Prevention Programs | Yale Scholarship Online
Users without a subscription are not able to see the full content.

Quantitative Evaluation of HIV Prevention Programs

Edward H. Kaplan and Ron Brookmeyer

Abstract

How successful are HIV prevention programs? Which HIV prevention programs are most cost effective? Which programs are worth expanding and which should be abandoned altogether? This book addresses the quantitative evaluation of HIV prevention programs, assessing several different quantitative methods of evaluation. The book includes chapters by behavioral scientists, biologists, economists, epidemiologists, health service researchers, operations researchers, policy makers, and statisticians. The chapters present a wide variety of perspectives on the subject, including an overview of HIV prevent ... More

Keywords: HIV, HIV prevention programs, developing countries, economic analysis, costs effectiveness, resource allocation, Israel, blood donors

Bibliographic Information

Print publication date: 2001 Print ISBN-13: 9780300087512
Published to Yale Scholarship Online: October 2013 DOI:10.12987/yale/9780300087512.001.0001

Authors

Affiliations are at time of print publication.

Edward H. Kaplan, editor

Ron Brookmeyer, editor

Show Summary Details

subscribe or login to access all content.

Contents

View:

Front Matter

Title Pages

[UNTITLED]

Contributors

Foreword

Introduction

Edward H. Kaplan and Ron Brookmeyer

Part One Evaluating HIV Prevention Programs: Context and Concepts

Chapter 1 Overview of HIV Prevention Programs in Developing Countries

Michael H. Merson and Julia M. Dayton

Chapter 2 Implications of Economic Evaluations for National HIV Prevention Policy Makers

David R. Holtgrave and Steven D. Pinkerton

Chapter 3 Statistical Issues in HIV Prevention

Ron Brookmeyer

Chapter 4 Epidemiological Issues in the Evaluation of HIV Prevention Programs

Nancy S. Padian and Stephen C. Shiboski

Part Two Cost-Effectiveness and Resource Allocation

Chapter 5 Difficult Choices, Urgent Needs: Optimal Investment in HIV Prevention Programs

Margaret L. Brandeau

Chapter 6 Methadone Treatment as HIV Prevention: Cost-Effectiveness Analysis

Harold Pollack

Chapter 7 Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use

Douglas K. Owens, Donna M. Edwards, and Ross D. Shachter

Part Three Case Studies

Chapter 8 Harm Reduction in Rome: A Model-Based Evaluation of Its Impact on the HIV-1 Epidemic

Massimo Arcà, Teresa Spadea, Ciulia Cesaroni, Marina Davoli, Annette D. Verster, and Carlo A. Perucci

Chapter 9 Evaluating Israel's Ethiopian Blood Ban

Edward H. Kaplan

Chapter 10 Feeding Strategies for Children of HIV-Infected Mothers: Modeling the Trade-Off Between HIV Infection and Non-HIV Mortality

James G. Kahn, Elliot Marseille, and Joseph Saba

Part Four New Methods for New Problems

Chapter 11 Design of HIV Trials for Estimating External Effects

Tomas Philipson

Chapter 12 Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines

Ira M. Longini Jr., Michael G. Hudgens, and M. Elizabeth Halloran

Chapter 13 Health Policy Modeling: Epidemic Control, HIV Vaccines, and Risky Behavior

Sally Blower, Katia Koelle, and John Mills

Chapter 14 Development and Validation of a Serologic Testing Algorithm for Recent HIV Seroconversion

Glen A. Satten, Robert S. Janssen, Susan Stramer, and Michael P. Busch

Chapter 15 Issues in Quantitative Evaluation of Epidemiologic Evidence for Temporal Variability of HIV Infectivity

Stephen C. Shiboski and Nancy S. Padian

End Matter

Index